PHP
AORT icon

Parkman Healthcare Partners’s Artivion AORT Stock Holding History

Parkman Healthcare Partners’s Portfolio AORT Stock Details AORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.12M Sell
138,940
-113,074
-45% -$3.16M 0.32% 68
2026
Q1 		$9.23M Buy
252,014
+33,345
+15% +$1.32M 0.95% 37
2025
Q4 		$9.97M Sell
218,669
-2,375
-1% -$106K 0.95% 39
2025
Q3 		$9.36M Buy
221,044
+28,339
+15% +$1.07M 0.98% 36
2025
Q2 		$5.99M Buy
192,705
+81,053
+73% +$2.19M 0.69% 54
2025
Q1 		$2.74M Buy
+111,652
New +$3.1M 0.33% 68

Other funds holding AORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Parkman Healthcare Partners's AORT Position: Q2 2026 in Review

Parkman Healthcare Partners reduced its Artivion (AORT) stake by 45% in Q2 2026, selling an estimated $3.16M and leaving 138,940 shares worth $3.12M. The position accounts for 0.32% of the portfolio, ranked #68.

Parkman Healthcare Partners first reported a position in AORT in Q1 2025 and has held it in 6 quarters since. The position peaked at $9.97M in Q4 2025. 206 funds tracked by Wall St. Rank hold AORT as of Q2 2026.

  • Parkman Healthcare Partners held 138,940 shares of Artivion worth $3.12M as of Q2 2026.
  • Parkman Healthcare Partners sold 113,074 Artivion shares in Q2 2026, an estimated $3.16M.
  • Artivion made up 0.32% of Parkman Healthcare Partners's portfolio in Q2 2026, its #68 holding.
  • Parkman Healthcare Partners first reported a position in Artivion in Q1 2025 and has held it in 6 quarters since.
  • Parkman Healthcare Partners's Artivion position peaked at $9.97M in Q4 2025.
  • 206 funds tracked by Wall St. Rank held Artivion as of Q2 2026.

Based on Parkman Healthcare Partners's 13F filing for Q2 2026, filed 14 Aug 2026.